SET pseudogene 12 (SETP12)

SET pseudogene 12 (SETP12) is classified as a processed pseudogene, meaning it originates from a functional SET gene transcript that has been reverse-transcribed and inserted into the genome without retaining the ability to code for a functional protein[5][7][6]. Like other pseudogenes, SETP12 contains sequence similarity to its parent gene but features mutations such as frameshifts or premature stop codons that render it non-functional for protein expression[4][6]. While some pseudogenes have regulatory roles, such as acting as microRNA decoys or influencing gene expression of their cognate genes, there is no published evidence indicating that SETP12 itself performs a known regulatory or biological function[7]. There is also no evidence supporting its direct involvement as a therapeutic target, biomarker, or as having interactions with drugs. Pseudogenes—overall—are being studied for roles in diseases, particularly cancer, due to their potential to influence gene regulation through non-coding RNA mechanisms, but SETP12 does not have any such annotations in current curated gene databases[1][7]. Thus, it is best considered a non-coding genomic element with potential but unproven regulatory effects.

Other names

SETP12